The glucocorticoid receptor inhibits the human prolactin gene expression by interference with Pit-1 activity

Molecular and Cellular Endocrinology

Volumn 134, Issue 2, 1997, Pages 129-137

  Nalda, Asunción M ^a   Martial, Joseph A ^a   Muller, Marc ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Glucocorticoid; Human prolactin; Pit 1; Regulation

Indexed keywords

GLUCOCORTICOID RECEPTOR; PROLACTIN; PROTEIN ANTIBODY; TRANSCRIPTION FACTOR PIT 1;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; EXPRESSION VECTOR; HORMONE RESPONSIVE ELEMENT; HUMAN; HYPOPHYSIS CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; COS CELLS; CYCLIC AMP; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; PROLACTIN; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0030779649     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00176-7     Document Type: Article

References (33)

1. Adler S., Waterman M.L., He X., Rosenfeld M.G. Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell. 52:1988;685-695.
2. Akerblom J.E., Slater E.P., Beato M., Baxter J.D., Mellon P.L. Negative regulation by glucocorticoids through interference with a cAMP responsive element. Science. 241:1988;350-351.
3. Berwaer M., Monget P., Peers B., Mathy-Hartert M., Bellefroid E., Davis J.R.E., Belayew A., Martial J.A. Multi-hormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol. Cell. Endocrinol. 80:1991;53-64.
4. Camper S.A., Yao Y.A.S., Rottman F.M. Hormonal regulation of the bovine prolactin promoter in rat pituitary tumor cells. J. Biol. Chem. 260:1985;12246-12251.
5. Crenshaw E.B., Kall K., Simmons D.M., Swanson L.W., Rosenfeld M.G. Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements. Genes Dev. 3:1989;959-972.
6. Day R.N., Maurer R.A. The distal enhancer region of the rat prolactin gene contains elements conferring response to multiple hormones. Mol. Endocrinol. 3:1989;3-9.
7. De Camili P., Macconi D., Spada A. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature. 278:1979;252-254.
8. Drouin J., Sun Y.L., Chamberland M., Gauthier Y., De Lean A., Nemer M., Schmidt T.J. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12:1993;145-156.
9. Eggert, M., Muller, M., Renkawitz, R., 1995. The Glucocorticoid Receptor. In: Bauerle, P.A. (Ed.), Inducible gene expression, vol. 2, Birkhauser Verlag, Boston, pp. 131-156.
10. Elsholtz H.P., Lew A.M., Albert P.R., Sundmark V.C. Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. J. Biol. Chem. 226:1991;22919-22925.
11. Fox R.S., Jong T.C., Casanova J., Ye Z.S., Stanley F., Samuels H.H. The homeodomain protein, Pit-1/GHF-1, is capable of binding to and activating cell-specific elements of both the growth hormone and prolactin gene promoters. Mol. Endocrinol. 4:1990;1069-1080.
12. Giguère V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell. 46:1986;645-652.
13. Graham F.L., Van der Eb A.J. A new technique for the assay of human adenovirus 5 DNA. Virology. 52:1973;456-457.
14. Helmberg A., Auphan N., Caelles C., Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 3:1995;452-460.
15. Hoggard N., Davis J.R.E., Berwaer M., Monget P., Peers B., Belayew A., Martial J.A. Pit-1 binding sequences permit calcium regulation of human prolactin gene expression. Mol. Endocrinol. 5:1991;1748-1754.
16. Hollenberg S.M., Evans R.M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell. 55:1988;899-906.
17. Horwitz K.B., Costlow M.E., McGuire W.L. MCF-7: a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids. 26:1975;785-795.
18. Jonat C., Rahmsdorf H.J., Park K.-K., Cato A.C.B., Gebel S., Ponta H., Herrlich P. Anti-tumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
19. Lew A.M., Elsholtz H.P. Cloning of the human cDNA for transcription factor Pit-1. Nucleic Acids Res. 19:1991;6329.
20. Mangalam H.J., Albert V.R., Ingraham H.A., Kapiloff M., Wilson L., Nelson C., Elsholtz H., Rosenfeld M.G. A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev. 3:1989;946-958.
21. Murdoch G.H., Waterman M., Evans R.M., Rosenfeld M.G. Molecular mechanisms of phorbol esters, thyrotropin-releasing hormone, and growth factor stimulation of prolactin gene transcription. J. Biol. Chem. 260:1985;11852-11858.
22. Peers B., Voz M.L., Monget P., Mathy-Hartert M., Berwaer M., Belayew A., Martial J.A. Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Mol. Cell. Biol. 10:1990;4690-4700.
23. Peers B., Monget P., Nalda A.M., Voz M., Berwaer M., Belayew A., Martial J.A. Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-1. J. Biol. Chem. 266:1991;18127-18134.
24. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 91:1994;752-756.
25. Sakai D.D., Helms S., Carlstedt-Duke J., Gustafsson J.-A., Rottman F.M., Yamamoto K.R. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2:1988;1144-1154.
26. Samuels H.H., Stanley F., Casanova J. Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology. 105:1979;80-85.
27. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
28. Schüle R., Muller M., Kaltschmidt C., Renkawitz R. Many transcription factors interact synergistically with steroid receptors. Science. 242:1988;1418-1420.
29. Shapiro D.J., Sharp P.A., Wahli W.W., Keller M. A high-efficiency HeLa nuclear transcription extract. DNA. 7:1988;47-55.
30. Subramaniam N., Cairns W., Okret S. Studies on the mechanism of glucocorticoid-mediated repression from a negative glucocorticoid response element from the bovine prolactin gene. DNA Cell Biol. 16:1997;153-163.
31. Yan G.Z., Bancroft C. Mediation by calcium of thyrotropin-releasing hormone action on the prolactin promoter via transcription factor Pit-1. Mol. Endocrinol. 5:1991;1186-1189.
32. Yan G.Z., Pan W.T., Bancroft C. Thyrotropin-releasing hormone action on the prolactin promoter is mediated by the POU protein Pit-1. Mol. Endocrinol. 5:1991;535-541.
33. Yang-Yen H.-F., Chambond J.-C., Sun Y.-L., Smeal T., Schmidt T.J., Drouin J., Karin M. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 62:1990;1205-1215.